Pressmaster / Shuterstock.com
MRC Technology and the Institut Pasteur of Shanghai, Chinese Academy of Sciences (IPS-CAS) have agreed a partnership that will help develop new therapeutic antibodies.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
MRC Technology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, antibodies, IP, technology transfer, Dave Tapolczay,